These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 4141934)

  • 21. Adoptive transfer of experimental allergic encephalomyelitis: incubation of rat spleen cells with specific antigen.
    Richert JR; Driscoll BF; Kies MW; Alvord EC
    J Immunol; 1979 Feb; 122(2):494-6. PubMed ID: 84024
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Autoimmune effector cells. IV. Induction of experimental allergic encephalomyelitis in Lewis rats without adjuvant.
    Holda JH; Silberg D; Swanborg RH
    J Immunol; 1983 Feb; 130(2):732-4. PubMed ID: 6184402
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Immunoglobulin-deficient rats fail to develop experimental allergic encephalomyelitis.
    Willenborg DO; Prowse SJ
    J Neuroimmunol; 1983 Oct; 5(2):99-109. PubMed ID: 6194180
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Acute allergic encephalomyelitis (EAE) in the rat with special reference to immunologic and demyelinization effects.
    Piliero SJ; Cremonese P
    J Reticuloendothel Soc; 1973 Jul; 14(1):100-18. PubMed ID: 4126715
    [No Abstract]   [Full Text] [Related]  

  • 25. Suppression of experimental allergic encephalomyelitis by MBP-coupled lymphoid cells and by MBP-liposomes: a comparison.
    Strejan GH; St Louis J
    Cell Immunol; 1990 May; 127(2):284-98. PubMed ID: 1691689
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Abrogation of resistance to the reinduction of experimental allergic encephalomyelitis by pertussigen.
    Waxman FJ; Bergman RK; Munoz JJ
    Cell Immunol; 1982 Sep; 72(2):375-83. PubMed ID: 6185237
    [No Abstract]   [Full Text] [Related]  

  • 27. The presence of specific antigen-reactive cells during the induction, recovery, and resistance phases of experimental allergic encephalomyelitis.
    Waxman FJ; Fritz RB; Hinrichs DJ
    Cell Immunol; 1980 Jan; 49(1):34-42. PubMed ID: 6153156
    [No Abstract]   [Full Text] [Related]  

  • 28. [Electrophoretic mobility of lymph node cells in experimental allergic encephalomyelitis].
    Jenssen HL; Köhler H; Gundlach HJ; Günther J; Eckert R
    Acta Biol Med Ger; 1974; 32(1):113-9. PubMed ID: 4547024
    [No Abstract]   [Full Text] [Related]  

  • 29. Experimental allergic encephalitis: study of cellular immunity to the encephalitogenic determinant.
    Spitler LE; von Muller CM; Young JD
    Cell Immunol; 1975 Jan; 15(1):143-51. PubMed ID: 45837
    [No Abstract]   [Full Text] [Related]  

  • 30. In vitro response to basic protein in experimental allergic encephalomyelitis: effect of pretreatment with basic protein in incomplete adjuvant.
    Lisak RP; Zweiman B; Dzida L; Rosenblum F; Rorke LB; Barger G
    Cell Immunol; 1980 Jul; 52(2):443-50. PubMed ID: 6159988
    [No Abstract]   [Full Text] [Related]  

  • 31. Autoimmune effector cells. III. Role of adjuvant and accessory cells in the in vitro induction of autoimmune encephalomyelitis.
    Killen JA; Swanborg RH
    J Immunol; 1982 Aug; 129(2):759-63. PubMed ID: 6177781
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Experimental allergic encephalomyelitis in the Lewis rat: studies on the mechanism of recovery from disease and acquired resistance to reinduction.
    Willenborg DO
    J Immunol; 1979 Sep; 123(3):1145-50. PubMed ID: 313947
    [No Abstract]   [Full Text] [Related]  

  • 33. Lymphocyte suppression associated with alpha globulin. Changes in cellular immunity.
    Burger DR; Lilley DP; Vetto RM
    Cell Immunol; 1974 Mar; 10(3):432-41. PubMed ID: 4141932
    [No Abstract]   [Full Text] [Related]  

  • 34. The significance of circulating and cell-bound antibodies in experimental allergic encephalomyelitis.
    Gonatas NK; Gonatas JO; Stieber A; Lisak R; Suzuki K; Martenson RE
    Am J Pathol; 1974 Sep; 76(3):529-48. PubMed ID: 4547331
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Immunoregulation and drug treatment in chronic relapsing experimental allergic encephalomyelitis in the Lewis rat.
    Kovarik J; Chabannes D; Borel JF
    Int J Immunopharmacol; 1995 Apr; 17(4):255-63. PubMed ID: 7545648
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Neutral protease activity in lymphocytes of Lewis rats with acute experimental allergic encephalomyelitis.
    Smith ME
    Neurochem Res; 1979 Dec; 4(6):689-702. PubMed ID: 94652
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Oral tolerance in experimental autoimmune encephalomyelitis: specificity of peptide-induced oral tolerance.
    Javed NH; Gienapp I; Cox K; Whitacre CC
    Ann N Y Acad Sci; 1996 Feb; 778():393-4. PubMed ID: 8611001
    [No Abstract]   [Full Text] [Related]  

  • 38. Adoptive transfer of experimental allergic encephalomyelitis: requirement for macrophages in activation of spleen cells in vitro by concanavalin A or myelin basic protein.
    Panitch HS; Ciccone C
    Cell Immunol; 1981 May; 60(1):24-33. PubMed ID: 6165485
    [No Abstract]   [Full Text] [Related]  

  • 39. HgCl2-induced perturbation of the T cell network in experimental allergic encephalomyelitis. I. In vitro characterization of T cells involved.
    Rossert J; Pelletier L; Pasquier R; Villarroya H; Oriol R; Druet P
    Cell Immunol; 1991 Oct; 137(2):367-78. PubMed ID: 1716519
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Effect of HgCl2 on experimental allergic encephalomyelitis in Lewis rats. HgCl2-induced down-modulation of the disease.
    Pelletier L; Rossert J; Pasquier R; Villarroya H; Belair MF; Vial MC; Oriol R; Druet P
    Eur J Immunol; 1988 Feb; 18(2):243-7. PubMed ID: 2450757
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.